RFWA
VRTX icon

RPg Family Wealth Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

RPg Family Wealth Advisory’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-184
Closed -$15.8K – 272
2016
Q2 		$15.8K Sell
184
-52
-22% -$4.49K 0.01% 206
2016
Q1 		$18.8K Buy
+236
New +$21.3K 0.01% 197

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RPg Family Wealth Advisory's VRTX Position: Q3 2016 in Review

RPg Family Wealth Advisory sold out of Vertex Pharmaceuticals (VRTX) in Q3 2016, closing a stake of 184 shares — an estimated $15.8K sold.

RPg Family Wealth Advisory first reported a position in VRTX in Q1 2016 and held it in 2 quarters. The position peaked at $18.8K in Q1 2016. 491 funds tracked by Wall St. Rank hold VRTX as of Q3 2016.

  • RPg Family Wealth Advisory reported no remaining Vertex Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • RPg Family Wealth Advisory sold 184 Vertex Pharmaceuticals shares in Q3 2016, an estimated $15.8K.
  • RPg Family Wealth Advisory first reported a position in Vertex Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • RPg Family Wealth Advisory's Vertex Pharmaceuticals position peaked at $18.8K in Q1 2016.
  • 491 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2016.

Based on RPg Family Wealth Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.